Add Note Why Create Notes?

Capture your thoughts

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Walt Disney Co NYSE:DIS	Media

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

This note will be permanently deleted.

Delete

Cancel

Have any thoughts about
Novozymes A/S?

Write Note

Write Note Ask AI

Ask me anything about

Novozymes A/S

What unique competitive advantages
does Novozymes A/S hold over its rivals?

What risks and challenges
does Novozymes A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Novozymes A/S.

What unique competitive advantages
does Novozymes A/S hold over its rivals?

What risks and challenges
does Novozymes A/S face in the near future?

Summarize the latest earnings call
of Novozymes A/S.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Novozymes A/S.

Provide P/S
for Novozymes A/S.

Provide P/E
for Novozymes A/S.

Provide P/OCF
for Novozymes A/S.

Provide P/FCFE
for Novozymes A/S.

Provide P/B
for Novozymes A/S.

Provide EV/S
for Novozymes A/S.

Provide EV/GP
for Novozymes A/S.

Provide EV/EBITDA
for Novozymes A/S.

Provide EV/EBIT
for Novozymes A/S.

Provide EV/OCF
for Novozymes A/S.

Provide EV/FCFF
for Novozymes A/S.

Provide EV/IC
for Novozymes A/S.

Show me price targets
for Novozymes A/S made by professional analysts.

What are the Revenue projections
for Novozymes A/S?

How accurate were the past Revenue estimates
for Novozymes A/S?

What are the Net Income projections
for Novozymes A/S?

How accurate were the past Net Income estimates
for Novozymes A/S?

What are the EPS projections
for Novozymes A/S?

How accurate were the past EPS estimates
for Novozymes A/S?

What are the EBIT projections
for Novozymes A/S?

How accurate were the past EBIT estimates
for Novozymes A/S?

Compare the revenue forecasts
for Novozymes A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Novozymes A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Novozymes A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Novozymes A/S compared to its peers.

Compare the P/E ratios
of Novozymes A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Novozymes A/S with its peers.

Analyze the financial leverage
of Novozymes A/S compared to its main competitors.

Show all profitability ratios
for Novozymes A/S.

Provide ROE
for Novozymes A/S.

Provide ROA
for Novozymes A/S.

Provide ROIC
for Novozymes A/S.

Provide ROCE
for Novozymes A/S.

Provide Gross Margin
for Novozymes A/S.

Provide Operating Margin
for Novozymes A/S.

Provide Net Margin
for Novozymes A/S.

Provide FCF Margin
for Novozymes A/S.

Show all solvency ratios
for Novozymes A/S.

Provide D/E Ratio
for Novozymes A/S.

Provide D/A Ratio
for Novozymes A/S.

Provide Interest Coverage Ratio
for Novozymes A/S.

Provide Altman Z-Score Ratio
for Novozymes A/S.

Provide Quick Ratio
for Novozymes A/S.

Provide Current Ratio
for Novozymes A/S.

Provide Cash Ratio
for Novozymes A/S.

What is the historical Revenue growth
over the last 5 years for Novozymes A/S?

What is the historical Net Income growth
over the last 5 years for Novozymes A/S?

What is the current Free Cash Flow
of Novozymes A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Novozymes A/S.

Novozymes A/S
CSE:NZYM B

Watchlist Manager

Novozymes A/S

CSE:NZYM B

Watchlist

Earnings Calls

Price: 403 DKK -3.93%

Updated: Jun 11, 2024

NZYM B

Income Statement

Income from Continuing Operations

Novozymes A/S
Income from Continuing Operations

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Novozymes A/S
Income from Continuing Operations Peer Comparison

Comparables:

CHR

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company		Income from Continuing Operations	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Novozymes A/S CSE:NZYM B	Income from Continuing Operations kr3B	CAGR 3-Years 2%	CAGR 5-Years -1%	CAGR 10-Years N/A
	Chr Hansen Holding A/S CSE:CHR	Income from Continuing Operations €227m	CAGR 3-Years -1%	CAGR 5-Years 0%	CAGR 10-Years 5%

What is Novozymes A/S's Income from Continuing Operations?

Income from Continuing Operations
3B DKK

Based on the financial report for Dec 31, 2023, Novozymes A/S's Income from Continuing Operations amounts to 3B DKK.

What is Novozymes A/S's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 5Y
-1%

Over the last year, the Income from Continuing Operations growth was -18%. The average annual Income from Continuing Operations growth rates for Novozymes A/S have been 2% over the past three years , -1% over the past five years .

Novozymes A/S
CSE:NZYM B

Novozymes A/S
Income from Continuing Operations

Novozymes A/S
Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

See Also

What is Novozymes A/S's Income from Continuing Operations?

Income from Continuing Operations
3B DKK

What is Novozymes A/S's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 5Y
-1%

Company

Help

Tools

Stocks

Novozymes A/S CSE:NZYM B

Novozymes A/S Income from Continuing Operations

Novozymes A/S Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis Latest Figures & CAGR of Competitors

See Also

What is Novozymes A/S's Income from Continuing Operations? Income from Continuing Operations 3B DKK

What is Novozymes A/S's Income from Continuing Operations growth rate? Income from Continuing Operations CAGR 5Y -1%

Company

Help

Tools

Stocks

Novozymes A/S
CSE:NZYM B

Novozymes A/S
Income from Continuing Operations

Novozymes A/S
Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

What is Novozymes A/S's Income from Continuing Operations?

Income from Continuing Operations
3B DKK

What is Novozymes A/S's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 5Y
-1%